Table 3.
Greater Areas of Activity in DRD4.L Group Compared With the Control Group
Region | BA | Peak Z-score | TLRC |
---|---|---|---|
DRD4.L > Controls | |||
Prepriming | |||
L OFC* | 47 | 3.17 | −42, 43, −5 |
L subcallosal gyrus | 25 | 3.10 | −10, 19, −15 |
L IFG | 47 | 2.92 | −36, 29, −15 |
R putamen | – | 2.79 | 24, 11, −7 |
L OFC* | 47 | 2.54 | −14, 23, −15 |
R insula | 13 | 2.41 | 28, 17, −7 |
R OFC | 11 | 2.26 | 40, 45, −13 |
R OFC | 11 | 2.21 | 12, 25, −15 |
R VTA/midbrain | – | 1.90 | 10, −17, −15 |
Postpriming | |||
None | |||
Controls > DRD4.L | |||
Prepriming | |||
R medial frontal gyrus | 10 | 3.65 | 20, 43, −1 |
L ACG | 32 | 3.38 | 16, 33, 7 |
R caudate | – | 3.05 | 22, 21, 5 |
R ACG | 32 | 2.90 | 16, 41, −1 |
L caudate | – | 2.66 | −18, 27, 1 |
R IFG | 11 | 1.78 | 26, 31, −25 |
Postpriming | |||
R IFG | 47 | 3.93 | 23, 31, −11 |
L OFC | 11 | 3.64 | −24, 35, −13 |
L caudate | – | 3.58 | 22 27 −7 |
R globus pallidus | – | 3.57 | 20, −13, −5 |
L thalamus | – | 3.35 | −10, −3, −13 |
R VTA/midbrain | – | 3.30 | 14, −9, −9 |
R putamen | – | 3.21 | −10, 5, −9 |
R ACG | 32 | 2.99 | 18, 33, −11 |
L VTA/midbrain | – | 2.87 | −6, −19, −9 |
L putamen | – | 2.80 | −24, 9, −7 |
R thalamus | – | 2.70 | 18, −5, 13 |
L, left; R, right; OFC, orbitofrontal cortex; IFG, inferior frontal gyrus; VTA, ventral tegmental area; ACG, anterior cingulate gyrus.
Without priming, the DRD4.L subjects had greater BOLD response in all of the ROIs compared to the controls (p < 0.05). None of these structures was greater in the DRD4.L subjects after priming. Maximum loci of activation are listed for each substrate as anatomical labels, Brodmann area (BA) corresponding peak z-score, and Talairach (TLRC) co-ordinates corresponding of greater BOLD response in the risk allele group compared with the nonrisk allele group.
Foci of peak activation (i.e., L OFC) that overlap with OPRM1.G individuals.